Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez AD, Sánchez-Acuña G. Comparison of the value of PCNA and Ki-67as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e174-9.

doi:10.4317/medoral.18573

http://dx.doi.org/doi:10.4317/medoral.18573

1. Van Diest PJ, Brugal G, Baak JP. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol.1998;51:716-24.
http://dx.doi.org/10.1136/jcp.51.10.716
PMid:10023332 PMCid:500923

2. Bishop JM. The molecular genetics of cancer. Science. 1987;235:305-11.
http://dx.doi.org/10.1126/science.3541204
PMid:3541204

3. Tumuluri V, Thomas GA, Fraser IS. Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med. 2002;31:598-604.
http://dx.doi.org/10.1034/j.1600-0714.2002.00042.x
PMid:12406305

4. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 2000;36:256-63.
http://dx.doi.org/10.1016/S1368-8375(00)00007-5

5. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20.
http://dx.doi.org/10.1002/ijc.2910310104
PMid:6339421

6. Ihmann T, Liu J, Schwabe W, Häusler P, Behnke D, Bruch HP, et al. High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma. J Cancer Res Clin Oncol. 2004;130:749-56.
http://dx.doi.org/10.1007/s00432-004-0612-5
PMid:15449182

7. Kelman Z. PCNA: structure, functions and interactions. Oncogene. 1997;14:629-40.
http://dx.doi.org/10.1038/sj.onc.1200886
PMid:9038370

8. de Oliveira MG, Lauxen Ida S, Chaves AC, Rados PV, Sant'AnaFilho M. Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions. Med Oral Patol Oral Cir Bucal. 2008;13:E275-80.
PMid:18449109

9. Mighell A. PCNA and p53. Eur J Cancer B Oral Oncol. 1995;31B:403-4.
http://dx.doi.org/10.1016/0964-1955(95)00037-2

10. De Biasio A, Sánchez R, Prieto J, Villate M, Campos-Olivas R, Blanco FJ. Reduced stability and increased dynamics in the human proliferating cell nuclear antigen (PCNA) relative to the yeast homolog. PLoS One. 2011;6:e16600.
http://dx.doi.org/10.1371/journal.pone.0016600
PMid:21364740 PMCid:3041752

11. Oka S, Uramoto H, Shimokawa H, Iwanami T, Tanaka F. The expression of Ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung. Anticancer Res. 2011;31:4277-82.
PMid:22199292

12. Mateoiu C, Pirici A, Bogdan F. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma. Rom J Morphol Embryol. 2011;52:315-9.
PMid:21424069

13. Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian AH, Ghazi N, Rajaei AR, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoidodontogenic tumor. J Oral Sci. 2011;53:213-7.
http://dx.doi.org/10.2334/josnusd.53.213
PMid:21712626

14. Saghafi S, Zare-Mahmoodabadi R, Salehinejad J, Kadeh H, Afzal-Aghaee M. Immunohistochemical analysis of p53 and PCNA expression in calcifying odontogenic cyst. J Oral Sci. 2010;52:609-13.
http://dx.doi.org/10.2334/josnusd.52.609
PMid:21206164

15. Ahmed MM, El-Azab SM. Evaluation of cell cycle-related indicators in plexiform ameloblastoma. J Egypt Natl Canc Inst. 2008;20:294-301.
PMid:20424660

16. Figueroa A, Correnti M, Avila M, Andea A, DeVilliers P, Rivera H. Keratocystic odontogenic tumor associated with nevoid basal cell carcinoma syndrome: similar behavior to sporadic type?. Otolaryngol Head Neck Surg. 2010;142:179-83.
http://dx.doi.org/10.1016/j.otohns.2009.10.008
PMid:20115971

17. Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg. 2006;35:1005-10.
http://dx.doi.org/10.1016/j.ijom.2006.07.016
PMid:17018251

18. Pontes HA, Pontes FS, Silva BS, Cury SE, Fonseca FP, Salim RA, et al. Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma. Ann Diagn Pathol. 2010;14:447-52.
http://dx.doi.org/10.1016/j.anndiagpath.2009.10.007
PMid:21074695

19. Barnes L, Eveson JW, Reichart P, Sidransky D.: World health organization classification of tumors. Pathology and genetics head and neck tumors. (eds). Lyon: IARC Press;2005.

20. Bologna-Molina R, Damián-Matsumura P, Molina-Frechero N. An easy cell counting method for immunohistochemistry that does not use an image analysis program. Histopathology. 2011;59:801-3.
http://dx.doi.org/10.1111/j.1365-2559.2011.03954.x
PMid:21939456

21. Meer S, Galpin JS, Altini M, Coleman H, Ali H. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:213-21.
http://dx.doi.org/10.1067/moe.2003.62
PMid:12582363

22. Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol. 2001;37:193-8.
http://dx.doi.org/10.1016/S1368-8375(00)00079-8

23. Li TJ, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology. 1995;26:219-28.
http://dx.doi.org/10.1111/j.1365-2559.1995.tb01435.x

24. Liu M, Lawson G, Delos M, Jamart J, Ide C, Coche E, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki-67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck. 2003;25:280-8.
http://dx.doi.org/10.1002/hed.10218
PMid:12658732

25. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes ameloblastomas. Oral Oncol. 2008;44:805-11.
http://dx.doi.org/10.1016/j.oraloncology.2007.10.007
PMid:18207448

26. Mighell A. Proliferating cell nuclear antigen. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:3-4.
http://dx.doi.org/10.1016/S1079-2104(95)80006-9

27. Otali D, Stockard CR, Oelschlager DK, Wan W, Manne U, Watts SA, et al. Combined effects of formalin fixation and tissue processing on immunorecognition. Biotech Histochem. 2009;84:223-47.
PMid:19886759 PMCid:2903968

28. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22.
http://dx.doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9

29. Heidebrecht HJ, Buck F, Haas K, Wacker HH, Parwaresch R. Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the "Ki- 67" proteins. Cell Prolif. 1996;29:413-425.
http://dx.doi.org/10.1111/j.1365-2184.1996.tb00984.x
PMid:8883465